Canaccord Genuity Raising PT and Estimates on ResMed (RMD); Solid Q4
Tweet Send to a Friend
Canaccord Genuity maintains a 'Hold' on ResMed (NYSE: RMD) price target of $36.00 (from $32.00).
Analyst, Jason R. Mills ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Jason R. Mills ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
